1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A DKMS (German Bone Marrow Donor Center) view on cryopreservation of unrelated donor stem cell products during the COVID-19 pandemic
    Correspondence

    Schmidt, A. H.; Buk, D.; Bernas, S. N.; Mengling, T.; Neujahr, E.; van den Brink, M. R. M.
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • IL-22-dependent dysbiosis and mononuclear phagocyte depletion contribute to steroid-resistant gut graft-versus-host disease in mice
    Journal Article

    Song, Q.; Wang, X.; Wu, X.; Kang, T. H.; Qin, H.; Zhao, D.; Jenq, R. R.; van den Brink, M. R. M.; Riggs, A. D.; Martin, P. J.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors
    Journal Article

    Valero, C.; Lee, M.; Hoen, D.; Weiss, K.; Kelly, D. W.; Adusumilli, P. S.; Paik, P. K.; Plitas, G.; Ladanyi, M.; Postow, M. A.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Risk of infections in patients with myeloproliferative neoplasms - A population-based cohort study of 8363 patients
    Journal Article

    Landtblom, A. R.; Andersson, T. M. L.; Dickman, P. W.; Smedby, K. E.; Eloranta, S.; Batyrbekova, N.; Samuelsson, J.; Björkholm, M.; Hultcrantz, M.
    Leukemia (2021)

    Fulltext@MSK | Save
  • Immune checkpoint blockade in renal cell carcinoma
    Review

    Rappold, P. M.; Silagy, A. W.; Kotecha, R. R.; Hakimi, A. A.
    Journal of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Routine evaluation of minimal residual disease in myeloma using next-generation sequencing clonality testing: Feasibility, challenges, and direct comparison with high-sensitivity flow cytometry
    Journal Article

    Ho, C.; Syed, M.; Roshal, M.; Petrova-Drus, K.; Moung, C.; Yao, J.; Quesada, A. E.; Benhamida, J.; Vanderbilt, C.; Liu, Y.; more...
    Journal of Molecular Diagnostics (2021)

    Fulltext@MSK | Save
  • Success and failure of additional immune modulators in steroid-refractory/resistant pneumonitis related to immune checkpoint blockade
    Journal Article

    Beattie, J.; Rizvi, H.; Fuentes, P.; Luo, J.; Schoenfeld, A.; Lin, I. H.; Postow, M.; Callahan, M.; Voss, M. H.; Shah, N. J.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Myeloid/lymphoid neoplasms with eosinophilia/basophilia and ETV6-ABL1 fusion: Cell-of-origin and response to tyrosine kinase inhibition
    Research Letter

    Yao, J.; Xu, L.; Aypar, U.; Meyerson, H. J.; Londono, D.; Gao, Q.; Baik, J.; Dietz, J.; Benayed, R.; Sigler, A.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • Proceedings from the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15th–16th February 2019, Doha, Qatar
    Review

    Guerrouahen, B.; Elnaggar, M.; Al-Mohannadi, A.; Kizhakayil, D.; Bonini, C.; Benjamin, R.; Brentjens, R.; Buchholz, C. J.; Casorati, G.; Ferrone, S.; more...
    Frontiers in Immunology (2021)

    Fulltext@MSK | Save
  • The effect of SF3B1 mutation on the DNA damage response and nonsense-mediated mRNA decay in cancer
    Journal Article

    Leeksma, A. C.; Derks, I. A. M.; Kasem, M. H.; Kilic, E.; de Klein, A.; Jager, M. J.; van de Loosdrecht, A. A.; Jansen, J. H.; Navrkalova, V.; Faber, L. M.; more...
    Frontiers in Oncology (2021)

    Fulltext@MSK | Save